AN UNBIASED VIEW OF SPIDER-VENOM PEPTIDES AS THERAPEUTICS

The sooner study (31) (N=56 patients) observed higher levels of retrospectively assessed acute strain disorder signs and existing PTSD indicators among patients who acquired enantiomer esketamine, compared with those that received racemic ketamine or opioids; the racemic ketamine group also confirmed mildly elevated acute tension disorder indicator